Home > Analytics > TTK HEALTHCARE

TTK HEALTHCARE
Intrinsic Value | Fundamental Analysis

BOM : 507747     NSE : TTKHLTCARE    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Dec 30,2024
Price(EOD): ₹ 1,405.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 1,981.33 Cr
Value of ₹ 1 Lac invested in TTK HEALTHCARE
on Dec 30,2019 (price: ₹ 475.00)

₹ 1 L

₹ 2.96 L

1W : -1.7% 1M : -3.6% 1Y : 7.2%
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
TTK HEALTHCARE -1.7% -3.6% 7.2%
SUN PHARMACEUTICAL INDUSTRIES 3.7% 8.5% 49.4%
CIPLA 3% 1.9% 20.9%
DR REDDYS LABORATORIES 2.7% 15.5% 23.2%
ZYDUS LIFESCIENCES -1.6% 1% 43.9%
DIVIS LABORATORIES 3.6% 1.8% 52.1%
MANKIND PHARMA -4.9% 11.4% 49.2%
TORRENT PHARMACEUTICALS -1.4% 5.3% 49.3%
LUPIN 6.9% 15.6% 73.7%

FUNDAMENTAL ANALYSIS OF TTK HEALTHCARE

 
Fundamentals Score
[ Q(TTM): Sep2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF TTK HEALTHCARE

 
Valuation Score
[As on : Dec 30,2024 ]

Ratio Standalone
P/E
P/B
P/S
24.84
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 79.94 Cr
[Latest Qtr - Sep2024 - Standalone Results ]

1.98
P/B Calculated based on Book Value of Rs 1,000.92 Cr
[Latest Year - Mar2024 - Standalone Results ]

2.57
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2024 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 9% undervalued companies ! Discover More →

FAIR VALUE OF TTK HEALTHCARE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
50%
13%
71%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF TTK HEALTHCARE



TTK HEALTHCARE vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF TTK HEALTHCARE

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0.02
0.03
0.06
0.04
-
-
-
-
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF TTK HEALTHCARE

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF TTK HEALTHCARE

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-4.53%
19.13%
-43.16%
-45.52%
6.85%
-13.71%
7.57%
7.46%
QtrlyTrend
0
Latest Qtr: Sep2024
Quarterly Result Analysis →


TTK HEALTHCARE related INDICES

BSE Indices1W1M1Y
S&P BSE ALLCAP -0.3% -3.5% 35.8%
S&P BSE SMALL CAP -0.7% 0.4% 30.5%
S&P BSE INDUSTRIALS -1.9% -2.9% 29.3%
S&P BSE MIDSMALLCAP -2.3% 1.6% 31.3%
No NSE index found

You may also like the below Video Courses


FAQ about TTK HEALTHCARE


Is TTK HEALTHCARE good for long term investment?

As on Dec 30,2024, the Fundamentals of TTK HEALTHCARE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of TTK HEALTHCARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is TTK HEALTHCARE UnderValued or OverValued?

As on Dec 30,2024, TTK HEALTHCARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of TTK HEALTHCARE ?

As on Dec 30,2024, the Intrinsic Value of TTK HEALTHCARE is Rs. 938.94 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 938.94
Fair Value [Median EV / Sales Model] : Rs. 1,248.11
Fair Value [Median Price / Sales Model] : Rs. 821.93
Estimated Median Fair Value of TTK HEALTHCARE : Rs. 938.94

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is TTK HEALTHCARE trading at a Premium or Discount?

As on Dec 30,2024, TTK HEALTHCARE is trading at a Premium of 50% based on the estimates of Median Intrinsic Value!